Per- and polyfluoroalkyl substances

Per- and polyfluoroalkyl substances has been studied in 75 papers since 2020: 1 trial and 54 observational studies in people, 2 in animals, 18 reviews; 47 in the past year. It has not reached trials in people. The newest paper, Nov 17, 2026: “Serum Per- and Polyfluoroalkyl Substances and Urinary Phthalate Metabolite Concentrations in Relation to a Novel Marker for…”.

ExposurePreclinical

75 papers study it58 findingsUpdated

9 new papers in 30 daysSee all 74 papers on per- and polyfluoroalkyl substances

At a glance

PFAS exposure is associated with higher PhenoAge and KDM biological age in human observational studies, although another biological-age measure shows no clear link. Human studies also link exposure with stroke and, in older adults, type 2 diabetes; individual-chemical analyses show no clear diabetes link. Studies report no clear links with telomere length or sarcopenia.

58 findings in 41 papers from 2022 to 2026, 18 of them since April 2026

The findings reach people, from one lab or study. 29 independent labs in 10 countries.

“WQS regression indicated that PFAS mixtures were positively associated with stroke risk (OR = 1.52; 95% CI: 1.17-1.97)”
Revealing the Link Between Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Stroke: A Comprehensive Epidemiological and Network Toxicology PerspectiveCardiovascular toxicology2026doi:10.1007/s12012-026-10157-0

2 of its findings point the other way.

Mice and humans: a single group. Cells and worms or flies: nothing yet.
  • 29 independent labs in 10 countries
  • 2 findings against
  • Funders: National Natural Science Foundation of China and others
  • Human trial1
  • Humans53
  • Animals2

What did studies of per- and polyfluoroalkyl substances find?

20

Studies of per- and polyfluoroalkyl substances measured 20 outcomes, among them metabolic syndrome, blood pressure trajectories and estimated glomerular filtration rate.

Metabolic syndrome

no changein humans2

2 studies
  1. Per- and polyfluoroalkyl substances were not clearly linked with metabolic syndrome in the general adult population.

    “No significant associations between legacy PFAS exposure and MetS risk were observed in the general adult population.”

    Humansin the general adult population

    The association between exposure to per- and polyfluoroalkyl substances and the risk of metabolic syndrome in adults: A systematic review and meta-analysis

    Ecotoxicology and environmental safety

  2. Per- and polyfluoroalkyl substances were not clearly linked with metabolic syndrome in humans (Prevalence ratio 0.90; 95% CI 0.74–1.19).

    “we observed null associations between the PFAS mixture and both MetS (prevalence ratio: 0.90; 95% CI: 0.74, 1.19)”

    Humansn = 1,071

    Exposure to per- and polyfluoroalkyl substances and adult cardiometabolic health: a Canadian Health Measures Survey mixture analysis

    Environmental health : a global access science source

More on Metabolic syndrome

Blood pressure trajectories

no changein humans1

1 study
  1. Per- and polyfluoroalkyl substances were not clearly linked with blood pressure trajectories in humans (Overall population of postmenopausal women).

    “neither average concentrations of individual PFAS nor PFAS mixtures were associated with BP trajectories in the overall population”

    HumansOverall population of postmenopausal womenIndividual substances and mixturesMedian follow-up of 5 yearsfemalesn = 641

    Per- and Polyfluoroalkyl Substances and Blood Pressure in Postmenopausal Women

    AHA Scientific Sessions 2026 abstract

Estimated glomerular filtration rate

downin humans1

1 study
  1. Per- and polyfluoroalkyl substances are linked with lower estimated glomerular filtration rate in humans (per quartile increase across models) (-2.2% to -2.9%).

    “PFAS mixture exposure was associated with reduced renal function, with eGFR decreases ranging from 2.2% to 2.9% per quartile increase across models”

    Humansper quartile increase across modelsn = 1,370

    Integrating lipid metabolomics and epidemiology: A mediation analysis of blood lipids between per- and polyfluoroalkyl substances (PFAS) and renal impairment

    Environmental pollution (Barking, Essex : 1987)

More on Estimated glomerular filtration rate

Inflammation

upin humans1

1 study
  1. Per- and polyfluoroalkyl substances increase inflammation in humans.

    “PFAS exposure promotes endothelial dysfunction, oxidative stress, chronic inflammation, lipid dysregulation, and genetic and epigenetic modifications”

    Review

    Imaging and Molecular Biomarkers of PFAS-Related Vascular Aging: A Narrative Review

    International journal of molecular sciences

More on Inflammation

Oxidative stress and ROS signaling

upin humans1

1 study
  1. Per- and polyfluoroalkyl substances increase oxidative stress and ROS signaling in humans.

    “PFAS exposure promotes endothelial dysfunction, oxidative stress, chronic inflammation, lipid dysregulation, and genetic and epigenetic modifications”

    Review

    Imaging and Molecular Biomarkers of PFAS-Related Vascular Aging: A Narrative Review

    International journal of molecular sciences

More on Oxidative stress and ROS signaling

Carotid intima-media thickness

upin humans1

1 study
  1. Per- and polyfluoroalkyl substances increase carotid intima-media thickness in humans.

    “PFAS exposure contributes to early vascular and atherosclerotic alterations detectable by imaging techniques, including increased carotid intima-media thickness (CIMT), arterial stiffness, and endothelial dysfunction.”

    Review

    Imaging and Molecular Biomarkers of PFAS-Related Vascular Aging: A Narrative Review

    International journal of molecular sciences

More on Carotid intima-media thickness

CERAD

downin humans1

1 study
  1. Per- and polyfluoroalkyl substances are linked with worse CERAD in humans (joint exposure with heavy metals).

    “The strongest negative signals at elevated joint exposure emerged for memory-related measures, notably CERAD Trials 1 and 2.”

    Humansjoint exposure with heavy metals

    Combined Effects of PFAS and Metals on Cognitive Function

    Environments (Basel, Switzerland)

More on CERAD

Breast cancer

no changein humans1

1 study
  1. Per- and polyfluoroalkyl substances were not clearly linked with breast cancer in humans (postmenopausal women).

    “We found no association between exposure to six commonly used PFAS and overall breast cancer risk in postmenopausal women.”

    Humanspostmenopausal womenfemales

    A case-control study of the association between per- and polyfluoroalkyl substances (PFAS) and risk of postmenopausal breast cancer in the Danish diet cancer and health cohort

    Environmental research

More on Breast cancer

Vascular dysfunction

upin humans1

1 study
  1. Per- and polyfluoroalkyl substances increase vascular dysfunction in humans.

    “elevated exposure to certain PFAS compounds may increase the risk of IHD and vascular dysfunction”

    Review

    Per- and Polyfluoroalkyl Substances Exposure as Emerging Cardiovascular Risk Factors: Implications for Ischemic Heart Disease

    Preprints.orgPreprint

QTc

upin humans1

1 study
  1. Per- and polyfluoroalkyl substances are linked with higher QTc in humans.

    “Higher PFAS burden was linked to prolonged QRS duration and QTc and shortened T-wave duration, consistent with altered ventricular depolarization and repolarization.”

    Humansn = 3,450

    Associations of Serum PFAS with Electrocardiographic Abnormalities in Older Adults and Electrophysiological Characterization

    Environmental science & technology

More on QTc

All 20

What is per- and polyfluoroalkyl substances linked with?

35

Studies link per- and polyfluoroalkyl substances with 35 measures, among them type 2 diabetes, fasting blood glucose and advanced immune aging.

Type 2 diabetes

upin humans1no changein humans1

2 studies
  1. Per- and polyfluoroalkyl substances are linked with a higher risk of type 2 diabetes in humans (elderly population).

    “Logistic regression identified PFDA, PFUnDA, and PFHpS as positively associated with T2DM risk (P < 0.05 and PFDR <0.2).”

    Humanselderly population

    Association of per- and polyfluoroalkyl substances exposure and type 2 diabetes risk with the mediating role of platelet mitochondrial DNA methylation in the elderly

    Ecotoxicology and environmental safety

  2. Per- and polyfluoroalkyl substances are associated with type 2 diabetes in humans (quantile-based g-computation analysis).

    “Quantile-based g-computation analysis showed an inverse association between the PFAS mixture and IFG and T2D risk, although these associations lacked statistical significance.”

    Humansquantile-based g-computation analysisn = 704

    Per- and polyfluoroalkyl substances and type 2 diabetes among older adults: Synthesizing cross-sectional population study and meta-analysis

    International journal of hygiene and environmental health

More on Type 2 diabetes

Fasting blood glucose

downin humans2

2 studies
  1. Per- and polyfluoroalkyl substances are associated with fasting blood glucose in humans (first-trimester exposure during pregnancy) (β -0.03, 95% CI -0.05 to -0.01).

    “The BKMR model results indicated that the PFAS mixture was negatively associated with FBG.”

    Humansfirst-trimester exposure during pregnancymixturenatural logarithm of the mixture increased from the median to the 60th percentilefemalesn = 314

    Effect of exposure to per- and polyfluoroalkyl substances in early pregnancy on blood glucose levels

    BMC pregnancy and childbirth

  2. Per- and polyfluoroalkyl substances are associated with fasting blood glucose in humans (-0.42, 95% CI: -1.12, 0.29).

    “exposure to PFAS mixtures was inversely, though not statistically significantly, associated with FBG levels (-0.42, 95% CI: -1.12, 0.29).”

    Humansserumn = 133

    Elevated serum levels of perfluorophosphonates among elderly residents living near e-waste dismantling areas and their associations with glucose homeostasis

    Journal of hazardous materials

More on Fasting blood glucose

Advanced immune aging

downin humans1

1 study
  1. Per- and polyfluoroalkyl substances are associated with advanced immune aging in humans (PRR 0.85, 95% CrI 0.77–0.93).

    “the same increase in the PFAS mixture was associated with lower risk (PRR: 0.85, 95% CrI: 0.77, 0.93).”

    HumansJoint increase from the 50th to the 75th percentilen = 2,479

    Serum Per- and Polyfluoroalkyl Substances and Urinary Phthalate Metabolite Concentrations in Relation to a Novel Marker for Immune Aging: A Cross-Sectional Study of U.S. Adults

    Research SquarePreprint

More on Advanced immune aging

Muscle function

mixedin humans1

1 study
  1. Per- and polyfluoroalkyl substances are associated with muscle function in humans (midlife exposure) (Unchanged or slightly better).

    “Women with higher plasma concentrations of select PFAS had small decrements in ALMI, but muscle function measures were unchanged or slightly better.”

    Humansmidlife exposurefemalesn = 551

    Associations of per- and polyfluoroalkyl substances (PFAS) with muscle mass and function in women in midlife

    Environmental epidemiology (Philadelphia, Pa.)

Appendicular lean mass index

downin humans1

1 study
  1. Per- and polyfluoroalkyl substances are associated with appendicular lean mass index in humans (midlife exposure).

    “Women with higher concentrations of perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUnDA), and the qgcomp PFAS mixture in midlife had lower ALMI”

    Humansmidlife exposureqgcomp PFAS mixturefemalesn = 551

    Associations of per- and polyfluoroalkyl substances (PFAS) with muscle mass and function in women in midlife

    Environmental epidemiology (Philadelphia, Pa.)

Systolic blood pressure

upin humans1

1 study
  1. Per- and polyfluoroalkyl substances are associated with systolic blood pressure in humans (Postmenopausal women).

    “PFAS mixtures were significantly associated with higher systolic and diastolic BP, with n-PFOA contributing the most.”

    HumansPostmenopausal womenmixtureBaselinefemalesn = 641

    Per- and Polyfluoroalkyl Substances and Blood Pressure in Postmenopausal Women

    AHA Scientific Sessions 2026 abstract

Estimated pulse wave velocity

upin humans1

1 study
  1. Per- and polyfluoroalkyl substances are associated with estimated pulse wave velocity in humans (high versus low mixture exposure in healthy adults) (1.284 m/s higher; 95% CI 1.078–1.490; P<0.001).

    “In doubly robust analysis, ePWV was 1.284 m/s higher in the high- than in low-mixture exposure group (95%CI:1.078-1.490; P<0.001).”

    Humanshigh versus low mixture exposure in healthy adultsmixture

    Positive association of exposure to per- and polyfluoroalkyl substances with arterial stiffness parameters and its interaction with sex hormone levels

    Nan fang yi ke da xue xue bao = Journal of Southern Medical University

More on Estimated pulse wave velocity

Stroke

upin humans1OR 1.52

1 study
  1. Per- and polyfluoroalkyl substances are linked with a higher risk of stroke in humans (OR = 1.52; 95% CI: 1.17-1.97).

    “WQS regression indicated that PFAS mixtures were positively associated with stroke risk (OR = 1.52; 95% CI: 1.17-1.97)”

    Humansserum

    Revealing the Link Between Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Stroke: A Comprehensive Epidemiological and Network Toxicology Perspective

    Cardiovascular toxicology

More on Stroke

Triglyceride-related lipid profiles

upin humans1

1 study
  1. Per- and polyfluoroalkyl substances are associated with triglyceride-related lipid profiles in humans.

    “PFAS exposure was associated with triglyceride-related lipid profiles in females.”

    Humansplasma-serumfemales

    Synthetic chemicals are linked to diabetes risk in women

    Environmental health perspectives

More on Triglyceride-related lipid profiles

Hyperlipidemia

upin humans1OR 1.57

1 study
  1. Per- and polyfluoroalkyl substances are linked with a higher risk of hyperlipidemia in humans (PFAS mixture analysis) (OR = 1.57; 95% CI: 1.22, 2.02).

    “Mixture analyses revealed a joint positive association (OR = 1.57; 95% CI: 1.22, 2.02)”

    HumansPFAS mixture analysis

    Healthy lifestyle modifies the association between per- and polyfluoroalkyl substances and hyperlipidemia: A propensity score-matched case-control study

    International journal of hygiene and environmental health

More on Hyperlipidemia

All 35

Funding

6 grants since 2020

National Institute of Environmental Health Sciences$4.9MNational Institute of General Medical Sciences$566KNational Cancer Institute$74.7K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies associate per- and polyfluoroalkyl substances with diminished ovarian reserve in females, stroke risk and diabetes risk in elderly people, but report no effect on metabolic syndrome in general adults. Four independent labs contribute, without replication of individual outcomes; the National Natural Science Foundation of China funds two of four findings.

  2. Summary written from the findings.

Latest

Dec 2025: 3Jan 2026: 3Feb 2026: 4Mar 2026: 3Apr 2026: 2May 2026: 9Jun 2026: 4Jul 2026: 3Aug 2026: 4Sep 2026: 3Oct 2026: 4Nov 2026: 446 papers in 12 months

See all 74 papers on per- and polyfluoroalkyl substances